K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · DVA
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2026-04-20 | DVA | DAVITA INC | DAVITA INC. | $1.2M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entities (KCE) benchmarks Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Exclusion of skin substitute spend from PY 2025 CKCC Kidney Contracting Entitie |
| 2026-04-20 | DVA | DAVITA INC. | RED+BLUE STRATEGIES | $70K | H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks. |
| 2026-04-20 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the budget and appropriations process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act |
| 2026-04-20 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $20K | Building support among disability and minority organizations in support of H.R. 6860 and S.1173. companion. |
| 2026-04-20 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2026-04-17 | DVA | DAVITA INC. | CONTINENTAL STRATEGY, LLC | $90K | Medicare and Medicaid reimbursement policies for specific kidney treatments. |
| 2026-04-17 | DVA | DAVITA INC. | S-3 GROUP | $60K | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS) |
| 2026-04-10 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2026-04-09 | DVA | DAVITA | PARK GOVERNMENT RELATIONS, LLC | $50K | Dialysis services, FY2027 mil.con./ Veterans Affairs Appropriations Act, S.275, S.3466 |
| 2026-04-01 | DVA | DAVITA INC. | TOM BRADLEY HEALTH POLICY LLC | $30K | |
| 2026-01-20 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protection Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to billing for skin substitute products in value-based care models Issues related to hospice and concurrent dialysis H.R. 6214/S. 2730, Kidney Care Access Protect |
| 2026-01-20 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prev |
| 2026-01-20 | DVA | DAVITA INC. | RED+BLUE STRATEGIES | $70K | H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. |
| 2026-01-20 | DVA | DAVITA INC. | S-3 GROUP | $60K | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS) |
| 2026-01-20 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2026-01-20 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Issues related to the FY2026 budget and appropriations process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S.1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act |
| 2026-01-20 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $20K | Building support among disability and minority organizations in support of H.R. 6860 and S.1173. companion. |
| 2026-01-20 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2026-01-19 | DVA | DAVITA INC. | CONTINENTAL STRATEGY, LLC | $90K | Medicare and Medicaid reimbursement policies for specific kidney treatments. |
| 2026-01-15 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2026-01-05 | DVA | DAVITA | PARK GOVERNMENT RELATIONS, LLC | $50K | Dialysis services, HR 5371, FY26 Continuing Approps, Agriculture, Legislative Branch, MCVA and Extensions Act |
| 2026-01-02 | DVA | DAVITA INC. | TOM BRADLEY HEALTH POLICY LLC | $30K | Issues related to the application of the Medicare Secondary Payer Act to dialysis services. |
| 2025-11-06 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2025-10-20 | DVA | DAVITA INC | DAVITA INC. | $1.0M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choic |
| 2025-10-20 | DVA | DAVITA INC. | CONTINENTAL STRATEGY, LLC | $90K | Medicare and Medicaid reimbursement policies for specific kidney treatments. |
| 2025-10-20 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Monitor issues related to the FY2026 budget process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S. 1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act |
| 2025-10-20 | DVA | DAVITA INC. | S-3 GROUP | $50K | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS) |
| 2025-10-20 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $20K | Building support among disability and minority organizations in support of H.R. 6860 and S.1173. companion. |
| 2025-10-19 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-10-11 | DVA | DAVITA INC. | RED+BLUE STRATEGIES( FORMERLY KNOWN AS NATHANSON+HAUCK) | $70K | H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for people living with ESRD. H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD |
| 2025-10-06 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-10-02 | DVA | DAVITA INC. | TOM BRADLEY HEALTH POLICY LLC | $30K | Issues related to the application of the Medicare Secondary Payer Act to dialysis services. |
| 2025-10-01 | DVA | DAVITA | PARK GOVERNMENT RELATIONS, LLC | $50K | Dialysis services, HR3944 - military construction, Veterans Affairs, and related agencies appropriations Act |
| 2025-07-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prev |
| 2025-07-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-07-21 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Monitor issues related to the FY2025 budget reconciliation process. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S. 1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act |
| 2025-07-21 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $20K | Building support among disability and minority organizations in support of /H.R. 6860 and Senate companion. |
| 2025-07-21 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2025-07-18 | DVA | DAVITA INC. | CONTINENTAL STRATEGY, LLC | $90K | Medicare and Medicaid reimbursement policies for specific kidney treatments. |
| 2025-07-18 | DVA | DAVITA INC. | S-3 GROUP | $50K | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS) |
| 2025-07-12 | DVA | DAVITA INC. | RED+BLUE STRATEGIES( FORMERLY KNOWN AS NATHANSON+HAUCK) | $70K | H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for people living with ESRD. H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD |
| 2025-07-12 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-07-10 | DVA | DAVITA INC. | TOM BRADLEY HEALTH POLICY LLC | $30K | Issues related to the application of the Medicare Secondary Payer Act to dialysis services. |
| 2025-07-01 | DVA | DAVITA | PARK GOVERNMENT RELATIONS, LLC | $50K | Dialysis services, HR3944 - military construction, Veterans Affairs, and related agencies appropriations Act |
| 2025-05-07 | DVA | DAVITA INC. | CONTINENTAL STRATEGY, LLC | $0 | Medicare and Medicaid reimbursement policies for specific kidney treatments. |
| 2025-04-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | Issues related to Veterans Affairs and dialysis Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis (no bill number) H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS |
| 2025-04-21 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 2199 and S.1173. |
| 2025-04-21 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. S. 1173: Restore Protections for Dialysis Patients Act H.R.2199 - Restore Protections for Dialysis Patients Act |
| 2025-04-21 | DVA | DAVITA INC. | S-3 GROUP | $50K | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Perspective Payment System (PPS) |
| 2025-04-21 | DVA | DAVITA INC | AVOQ, LLC | $20K | Issues related to Medicare payment for End Stage Renal Disease (ESRD) Issues related to health care workforce shortage |
| 2025-04-21 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2025-04-16 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $20K | Building support among disability and minority organizations in support of /H.R. 6860 and senate companion. |
| 2025-04-14 | DVA | DAVITA INC | APOLLO GOVERNMENT RELATIONS | $20K | HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD) HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD) |
| 2025-04-08 | DVA | DAVITA INC. | TOM BRADLEY HEALTH POLICY LLC | $30K | Issues related to the application of the Medicare Secondary Payer Act to dialysis services. |
| 2025-04-07 | DVA | DAVITA INC. | HORIZON GOVERNMENT AFFAIRS | $0 | |
| 2025-04-05 | DVA | DAVITA INC. | NATHANSON+HAUCK | $70K | H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease. H.R. 1968 - Full Year Continuing Resolution - Issues related to funding within the Department of Health and Human Services and its agencies,such as CMS. S. 891 - The Bipartisan Health Care Act - Policies impacting the treatment of dialysis patients covered by government and private insurance. H.R. 2199 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with End Stage Renal Disease. |
| 2025-04-03 | DVA | DAVITA | PARK GOVERNMENT RELATIONS, LLC | $50K | Dialysis services |
| 2025-02-07 | DVA | DAVITA INC. | S-3 GROUP | $0 | Issues related to dialysis payment policy, including End Stage Renal Disease (ESRD) Persepective Payment System (PPS) |
| 2025-01-30 | DVA | DAVITA INC. | COLETTE DESMARAIS | $0 | |
| 2025-01-21 | DVA | DAVITA INC | DAVITA INC. | $1.1M | H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspect |
| 2025-01-21 | DVA | DAVITA INC. | FEDERAL STREET STRATEGIES, LLC | $60K | Healthcare reimbursement policies; and issues relating to ESRD policies. Issues relating to ESRD policies and reimbursement. Issues related to the Medicare Secondary Payer Act. HR 6860 - Restore Protections for Dialysis Patients Act S. 5018 - Restore Protections for Dialysis Patients Act |
| 2025-01-21 | DVA | DAVITA INC. | WEST FRONT STRATEGIES LLC | $50K | Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis. Issues related to the National Dialysis Services Contracts. |
| 2025-01-21 | DVA | DAVITA INC | AVOQ, LLC | $50K | Issues related to Medicare payment for End Stage Renal Disease (ESRD); Issues related to H.R.6860, Restore Protections for Dialysis Patients Act Issues related to health care workforce shortage, including OMB's ESRD Prospective Payment System proposed rule |
| 2025-01-21 | DVA | DAVITA INC. | POWERS PYLES SUTTER & VERVILLE, P.C. | $10K | Building support among disability and minority organizations in support of /H.R. 6860 and senate companion. |
| 2025-01-20 | DVA | DAVITA INC | CAPITOL HILL CONSULTING GROUP | $60K | Issues related to Medicare ESRD payments and policy, including Medicare Advantage. Medicare reimbursement and Medicare Secondary Payer policies, including H.R. 6860. Issues surrounding Medicare reimbursement of oral ESRD drugs. |